Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
No Data
GT Biopharma Shareholders Approve Reverse Split and Incentive Plan
GT Biopharma Q2 EPS $(0.12) Misses $(0.08) Estimate
GT Biopharma Reports Q2 Results
GT Biopharma 2Q Research and Development Expenses About $1.1M >GTBP
Express News | GT Biopharma Inc - Cash Balance as of June 30, of About $5.1 Mln Anticipated to Provide Sufficient Cash Runway Through Q4 2026
GT Biopharma Reports Second Quarter 2026 Financial Results